Page last updated: 2024-10-27

fluorouracil and Hypophosphatemia

fluorouracil has been researched along with Hypophosphatemia in 1 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Hypophosphatemia: A condition of an abnormally low level of PHOSPHATES in the blood.

Research Excerpts

ExcerptRelevanceReference
"To assess S-1 and 5-fluorouracil (5-FU)-related adverse events in patients with advanced gastric cancer and provide focused health care approaches to improve patient compliance and quality of survival."3.01S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis. ( Chu, T; Hu, Q; Ke, J; Xu, J; Zhang, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Hu, Q1
Xu, J1
Ke, J1
Zhang, Z1
Chu, T1

Reviews

1 review available for fluorouracil and Hypophosphatemia

ArticleYear
S-1 and 5-Fluorouracil-related adverse events in patients with advanced gastric cancer: A meta-analysis.
    PloS one, 2023, Volume: 18, Issue:8

    Topics: Fluorouracil; Humans; Hypokalemia; Hypophosphatemia; Inflammation; Stomach Neoplasms; Stomatitis

2023